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and the presence of adsorbates on the 
surface of CNDs.[5] Accordingly, in the 
past decade, many research efforts have 
been devoted for modifying and control-
ling the surface characteristics of CNDs to 
expand their applicability.[6–10] In this con-
text, for instance, the photoluminescence 
(PL) wavelength could be controlled via 
the energy-level engineering,[6,7] the ion 
selectivity could be endowed for detecting 
metal ions,[8] and the biocompatibility 
could be improved for biomedical appli-
cations.[9–11] On the basis of these unique 
characteristics,[12,13] CNDs have been 
exploited for a variety of biomedical appli-
cations, such as diagnostic applications,[14] 
photoacoustic imaging, and the photo-
thermal therapy.[15–17]
Recently, multicolor PL nanomaterials have become greatly 
important in cell counting, cell sorting, diagnostics, and other 
therapeutic applications.[18] In flow cytometry, a single multi-
color agent can be used with multiple excitation and emission 
wavelengths for diverse commercial instruments. Furthermore, 
these multicolor agents show the stimuli responsive behaviors, 
enabling the applications to the multimodal sensing.[19] With 
the progress of light-guided therapies, multicolor PL nanomate-
rials are also expected to be used in various types of photothera-
pies including photodynamic therapy and optogenetic therapy. 
The optogenetics can be simply defined as the use of light to 
control cells in the living tissue. In accordance, the develop-
ment of multicolor-emitting CNDs becomes very important to 
expand the capabilities of CNDs for biomedical applications. 
So far, the tuning of PL colors of CNDs has been extensively 
investigated, but only few studies have reported the “intrinsic” 
multicolor PL.[20–22] The multicolor PL represents two or more 
distinct and totally independent PL colors generated from pos-
sibly different origins in contrast to the conventional excitation-
light-dependent PL reported elsewhere.[3,23]
Here, we developed dual-color-emitting CNDs (DC-CNDs) by 
controlling the electronic structure of CNDs through a facile sur-
face modification with 4-octyloxyaniline (Figure 1a). DC-CNDs 
could be stably encapsulated within water-soluble poly(styrene-
co-maleic anhydride) (PSMA), enabling biomedical applica-
tions to in vitro and in vivo dual-color bioimaging and light-
triggered activation of ion channel for optogenetic applications 
(Figure 1b). First, we have carried out in vitro cellular imaging 
with DC-CNDs by confocal and two-photon microscopy. In addi-
tion, we have visualized in vivo distribution of intravenously 
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Carbon Nanodots
Carbon nanodots (CNDs) have been widely investigated as new 
multifunctional nanoparticles for various applications ranging 
from optoelectronic devices to theranostic agents.[1–4] CNDs 
have a great potential as biocompatible optical materials that 
can be easily prepared from abundant carbon sources through 
facile synthetic methods. It has been known that the optical 
property of CNDs largely depends upon their surface states, or 
more specifically, their functional groups, the defect density, 
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injected DC-CNDs. Furthermore, we have demonstrated that 
two distinct PL of DC-CNDs could be used for selective acti-
vation of channelrhodopsin-2 (ChR2), a light-switched cation 
channel, reflecting the feasibility for optogenetic applications.
The pristine CNDs were prepared by the solvothermal car-
bonization of citric acid.[24] Then, the pristine CNDs were 
subject to surface modification with 4-octyloxyaniline to pre-
pare DC-CNDs (2–3 nm in size, Figure 2a).[25] The degree of 
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Figure 1. a) Schematic representation for the chemical structure of carbon nanodots (CNDs) showing the dual-color-emitting (DC) property (top) and 
the encapsulation of DC-CNDs into poly(styrene-co-maleic anhydride) (DC-CNDs@PSMA) (bottom). b) Schematic illustration for the applications of 
facile DC-CNDs to the fields of bioimaging and optogenetics.
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Figure 2. a) TEM images of dual-color-emitting carbon nanodots (DC-CNDs, scale bar = 10 nm). b) TEM images of poly(styrene-co-maleic anhydride) 
(PSMA) encapsulated DC-CNDs (left). The dotted area in the middle panel is magnified in the right panel (scale bar = 10 nm for left and 5 nm for right). 
c) Deconvoluted carbon (1s) XPS spectra of DC-CNDs. d) The absorption spectra of DC-CNDs. The inset is the expansion from 400 to 700 nm. The PL 
maps of e) DC-CNDs and f) the changes of PL as a function of surface functionalization degree controlled by varying the concentration of 4-octyloxyaniline. 
The used solvent was toluene. g) The emission structure of DC-CNDs. h) The photoimage of DC-CNDs under the illumination of 350 (left) or 600 nm 
(right) light. (i) The cytotoxicity of DC-CNDs@PSMA and quantum dots (Qdots) in FL83B cells.
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surface modification was carefully controlled by changing 
the concentration of 4-octyloxyaniline. The as-prepared DC-
CNDs then formed water-soluble composites with PSMA 
(DC-CNDs@PSMA) through hydrophobic interaction between 
the octyl group of DC-CNDs and the styrene group of PSMA 
(Figure S1, Supporting Information). The transmission elec-
tron microscopy (TEM) showed that DC-CNDs@PSMA was 
well-dispersed with a particle size of 3–6 nm (Figure 2b). The 
DC-CNDs@PSMA appeared to be composed of one to four 
DC-CNDs (Figure S2, Supporting Information). To inves-
tigate the chemical structure of DC-CNDs, we performed 
X-ray photo electron spectroscopy (XPS) and 13C nuclear mag-
netic resonance (NMR) analyses. The deconvoluted C1s XPS 
spectra indicated the presence of CC/CC (284.5 eV), CN 
(285.9 eV), and CO (288 eV) bondings on the surface of DC-
CNDs, likely due to oxidative carbonization (Figure 2c). 13C 
NMR was performed to analyze the surface chemistry of pris-
tine CNDs and DC-CNDs (Figure S3, Supporting Information). 
In Figure S3a (Supporting Information), pristine CNDs showed 
chemical shifts of 14.1, 22.7, 29.6, 31.9, 32.6 (alkyl) and 129.7, 
129.9 ppm (alkene) for the oleyl group, and 33.8 ppm for amido 
carbon, indicating that oleylamine was passivated on the sur-
face of CNDs. After modification with 4-octyloxyaniline, DC-
CNDs showed peaks at around 68.3, 132.3, and 158.6 ppm for 
methoxy, anilino, and phenoxy groups, together with the oleyl 
peaks, respectively (Figure S3b, Supporting Information). The 
results revealed the presence of partially substituted 4-octyloxy-
anilines on the surface of DC-CNDs. The 1H NMR spectrum 
of DC-CNDs@PSMA in Figure S3c (Supporting Information) 
showed the chemical shifts at 1.2, 1.8 (alkyl), 2.2 (arene-CH), 
3.1 (HOCH), 3.3 (OCNH), and 7.1 ppm (arene-H), indi-
cating the presence of PSMA on the surface of DC-CNDs. The 
surface functionalities of DC-CNDs have been further identi-
fied by the Fourier-transform infrared spectroscopy (Figure S4, 
Supporting Information). Both pristine CNDs and DC-CNDs 
exhibited the CO stretching (1690 cm−1) and NH bending 
(1500 cm−1) peaks, confirming the presence of carbonyl and 
amide (from oleylamine) groups on the surface of CNDs. After 
surface modification, the NH stretching (3500–3300 cm−1) 
and CO stretching (1260 cm−1) peaks were developed and the 
NH bending and CC stretching (1600–1450 cm−1) bands 
were intensified due to the chemical bonding of 4-octyloxyani-
line to the surface of CNDs.
The electronic structure and optical property of DC-CNDs 
were investigated by UV–vis absorption spectroscopy and PL 
spectroscopy. Figure 2d shows the absorption spectra of pris-
tine CNDs and DC-CNDs. Because both pristine CNDs and 
DC-CNDs showed two strong absorption peaks at around 300 
and 350 nm in common, the energy states related to the afore-
mentioned absorption peaks might be called “intrinsic” energy 
states. The first peak at 300 nm could be assigned to π–π* tran-
sitions that take place in the carbonized cores of CNDs. Because 
the π–π* gap of 5–8 fused benzene rings is 4–5 eV,[26,27] the core 
of CNDs might be composed of a few angstrom-sized polyaro-
matic carbon domains surrounded by the amorphous carbon 
matrix. The second peak at 350 nm might be assigned to n–π* 
transitions between the n-orbitals of heteroatoms (nitrogen 
and oxygen) and the π* orbitals of the polyaromatic domains. 
This presumably indicated that CNDs contained a significant 
amount of nitrogen and oxygen atoms originated from nitric 
acid as an oxidative carbonization catalyst and oleylamine as a 
surface passivation agent, respectively (Figure S5 and Table S1, 
Supporting Information). In comparison with pristine CNDs, 
DC-CNDs exhibited a significant absorption peak at 590 nm, 
indicating that a new energy state was developed by the sur-
face modification, so-called the “extrinsic” energy state. Due to 
the small size of CNDs only in the range of 2–3 nm, most of 
their polyaromatic domains would be exposed to the exterior. 
Accordingly, they can be readily modified with 4-octyloxyani-
line to form the extrinsic energy states.[25] The newly observed 
absorption showed the characteristics of n–π* transition, such 
as visible-range excitation and low extinction coefficient.[24,28] 
In Figure 2e, the PL data of DC-CNDs show two clearly dis-
cernible PL emissions with almost no spatial overlap at the 
wavelengths of 430 nm (blue, 370 nm excitation) and 600 nm 
(red, 570 nm excitation). By comparing the PL spectra of the 
pristine CNDs and DC-CNDs (Figure S6, Supporting Informa-
tion), it could be confirmed that the blue PL and the red PL 
were originated from intrinsic energy states and from extrinsic 
energy states, respectively. To investigate the reason for two dis-
tinct PL emissions, the degree of surface modification was con-
trolled by changing the concentration of 4-octyloxyaniline. With 
increasing modification, the intrinsic PL band disappeared, but 
the extrinsic PL peak increased significantly (Figure 2f). These 
results were matched well with the chemical structure of our 
CNDs described above. The polyaromatic domains responsible 
for intrinsic PL in the core of our CNDs would be converted 
to 4-octyloxyaniline-modified polyaromatic domains respon-
sible for extrinsic PL with the surface modification (Figure S7, 
Supporting Information). Furthermore, we examined the PL 
spectra of DC-CNDs before and after the PSMA encapsulation. 
As shown in Figure S8 (Supporting Information), the PSMA 
did not significantly change the optical properties of DC-
CNDs, because the hydrophobic chains of PSMA protected the 
chemical structures of DC-CNDs. There were only a slight red-
shift (≈5 nm) and the broadening of PL presumably due to the 
polarity change in surroundings induced by the PSMA. The 
quantum yield of DC-CNDs was ≈30% at 550 nm excitation, 
which was considered as the highest record among red-color-
emissive CNDs (Figure S9, Supporting Information).[25,29,30]
In order to explore the energy structure of DC-CNDs, 
we conducted time-resolved absorption (TA) spectroscopy 
and time-resolved PL (TRPL) spectroscopy. TA spectra were 
recorded to show the electronic transition in intrinsic and 
extrinsic states at the probe wavelength of 580 nm under the 
excitation wavelengths of 350 and 540 nm, respectively. Each 
of them corresponds to the transition energy of intrinsic and 
extrinsic states (Figure S10, Supporting Information). By the 
excitation at 350 nm, DC-CNDs exhibited excited state absorp-
tion (∆A > 0) on all timescales. The photoexcited electrons from 
intrinsic states were consumed to other accessible states, but 
were not allowed to access extrinsic states, indicating that the 
intrinsic states were localized in the polyaromatic domains 
and isolated from the 4-octyloxyaniline-modified polyaromatic 
domains. By the excitation at 540 nm, ∆A values showed strong 
stimulated emission (∆A < 0) even after 1 ns time delay. The 
photoexcited electrons from extrinsic states might be directly 
related to the red emission (580 nm). The TA spectra were fitted 
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using biexponential functions (Table S2, Supporting Informa-
tion). The relatively long decay time by the excitation at 540 nm 
might be attributed to the molecule-like, defectless characteris-
tics of extrinsic states.[25]
To investigate the dynamics of radiative recombination of DC-
CNDs, TRPL spectra were recorded at the probe wavelengths 
of 430 and 580 nm, each of which corresponds to the emission 
wavelengths from intrinsic and extrinsic states (Figure S11 and 
Table S3, Supporting Information). The TRPL spectra were well 
fitted to single exponential functions, reflecting that each emis-
sion state had one dominant radiative recombination pathway. 
The PL lifetime of extrinsic emission (3.1 ns) was longer than 
that of intrinsic emission (1.9 ns) in consistent with the TA decay 
time data. Furthermore, the PL lifetime of intrinsic emission of 
DC-CNDs (2.0 ns) was analogous to that of the pristine CNDs 
(2.4 ns) (Figure S12 and Table S4, Supporting Information), 
reflecting that there was no relaxation pathway of photoexcited 
electrons from intrinsic energy states to extrinsic energy states. 
From TA and TRPL spectra analysis, the electronic structure 
of DC-CNDs was schematically represented in Figure 2g. The 
important feature was that there was no energy transfer between 
intrinsic and extrinsic states, even the physical distance between 
the two states were very close to each other, probably less than 
the size of DC-CNDs (3 nm). Three reasons might be proposed 
for no energy transfer: (i) a significant energy difference, (ii) the 
insulating amorphous carbon matrix acting as a barrier for elec-
tronic transitions, and (iii) the perpendicular transition dipoles.[31]
For further biomedical applications, the cytotoxicity of DC-
CNDs was evaluated in the normal hepatocyte of FL83B cells 
(Figure 2i). The hepatocytes were incubated for 24 h with DC-
CNDs@PSMA dispersed in the cell culture media at the con-
centration range of 0.125–2 mg mL−1. DC-CNDs showed high 
cytocompatibility with a cell viability over 88% even at the high 
concentration of 2 mg mL−1. As a control group, we used com-
mercially available CdSe/ZnS quantum dots coated with a 
polymer bearing carboxyl groups, which showed high toxicity 
at the same concentrations. The low cytotoxicity of DC-CNDs@
PSMA was also confirmed in several different kinds of normal 
cells like embryonic kidney cells (HEK293) as well as cancer 
cells like hepatocellular carcinoma cells (HepG2) and skin mel-
anoma cells (B16F10) (Figure S13, Supporting Information).
In vitro cellular imaging was carried out in a skin melanoma 
cell of B16F10 cells to assess the performance of DC-CNDs as 
a bioimaging agent. After treatment with DC-CNDs@PSMA in 
the cell culture media at a concentration of 0.5 mg mL−1 for 
1 h, DC-CNDs@PSMA appeared to be internalized into the 
cells, showing the bright and robust fluorescence emission 
(Figure 3a). According to the confocal microscopic imaging, 
the cells labeled with DC-CNDs@PSMA showed different 
emission colors depending on the excitation wavelength. DC-
CNDs emitted blue fluorescence with excitation at 405 nm 
and red fluorescence with 561 nm. Because DC-CNDs showed 
high two-photon excitation, we could demonstrate their fea-
sibility as a two-photon imaging agent. With illumination of 
two-photon laser at 950 nm, DC-CNDs showed bright yellow 
and red colors. Furthermore, in HEK293, FL83B, and HepG2, 
DC-CNDs@PSMA was also readily internalized into the cells 
and emitted strong fluorescence, regardless of the shape and 
malignance of the cells (Figure S14, Supporting Information).
With a distinct absorption peak at 590 nm, DC-CNDs have 
been used for in vivo optical imaging to track the biodistribu-
tion and clearance of DC-CNDs@PSMA. The intravenously 
injected DC-CNDs@PSMA circulated and accumulated 
throughout the whole body, showing the bright fluorescence 
signal mainly in the lung. The fluorescence signal was the 
strongest at 24 h postinjection and then gradually decreased 
due to clearance. The surface encapsulation of nanoparticles 
with hydrophilic polymers has been known to mitigate the 
interaction of nanoparticles with macrophages in the mono-
nuclear phagocytic system, enhancing the circulation of the 
nanoparticles due to the reduced immune clearance.[32,33] The 
PSMA has been known to prolong the plasma half-life of con-
jugated molecules by binding to the serum albumin (ALB) in 
blood.[34] DC-CNDs@PSMA with an increased particle size also 
showed a relatively long circulation time compared with other 
CNDs reported elsewhere.[35]
Inspired by two different excitation and emission centers 
(Figure 2), we carried out a proof-of-concept study of DC-CNDs 
for optogenetic applications. Two different ion channels of neu-
rons were hypothesized to be controlled by the different emitted 
light of DC-CNDs depending on the excitation wavelength. 
ChR2 is one of the light-switched cation channels conducting 
H+, Na+, K+, and Ca2+ ions.[36] When ChR2 absorbs blue light, it 
opens rapidly to generate a large permeability for cations with 
the conformational change.[37] We transfected the DNA plasmid 
enclosing ChR2 with a tag protein of yellow fluorescent protein 
(YFP) into HEK293T cells with lipofectamine. Figure 4a shows 
the bright fluorescence of YFP on the confocal microscopic 
images to reflect the successful transfection of the plasmid with 
ChR2 into HEK293T cells. Both the control cells without ChR2 
and ChR2-introduced cells were incubated with 0.1 mg mL−1  
of DC-CNDs@PSMA solution for 1 h and then with the calcium 
indicator of Rhod-2 acetoxymethyl ester (AM). Figure 4b shows 
the confocal microscopic images of DC-CNDs and calcium 
indicators with or without laser illumination at 405 nm to com-
pare the red fluorescence intensity in the seven spots of region 
of interest. The control cells treated with DC-CNDs@PSMA 
showed the blue fluorescence of DC-CNDs under 405 nm 
laser illumination. The ChR2-introduced cells treated with DC-
CNDs@PSMA showed the slight blue fluorescence of DC-CNDs 
and the significantly increased red fluorescence (Figures 4b,c), 
reflecting the elevated calcium level by the opening of ChR2 
under the blue light emitted from DC-CNDs. Because blue 
light cannot be generated even under laser irradiation without 
the treatment of DC-CNDs, the ChR2-introduced cells showed 
only slight increase in the intensity of calcium indicators as 
a background signal. From the results, we could confirm the 
feasibility of DC-CNDs as a fluorophore to mediate the optoge-
netic control of neurons for the treatment of neuronal diseases. 
Using DC-CNDs, we can noninvasively deliver light of two dif-
ferent wavelengths to the neuron by injecting the single fluo-
rescent agent and activating it with different wavelength lasers. 
Thus, further optogenetic applications are expected using 
DC-CNDs as an alternative for invasive LED implantation to 
achieve the light-guided therapy.
Finally, we assessed in vivo acute toxicity of DC-CNDs 
using the collected blood samples and the dissected major 
organs 48 h after intravenous injection of DC-CNDs@PSMA. 
Adv. Sci. 2017, 4, 1700325
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According to the blood biochemistry study, the important 
hepatic indicators of total protein, ALB, total bilirubin, alka-
line phosphate did not show the sign of liver injury as shown 
in Figure 5a. In addition, the normal level of blood urea 
nitrogen and creatinine indicated the normal renal function 
of kidney and liver. Histological analysis of the dissected 
organs revealed no pathological changes or lesions in the 
lung, liver, kidney, and spleen (Figure 5b). These results con-
firmed the biocompatibility of DC-CNDs without causing the 
acute toxicity at the tested dose for further in vivo biomedical 
applications.
In conclusion, water-soluble DC-CNDs with two distinct exci-
tation and emission centers have been successfully developed 
via the facile surface modification with 4-octyloxyaniline. 
Figure 3. a) Multicolor confocal (top) and two-photon (bottom) microscopic images of B16F10 cells after treatment of dual-color-emitting carbon 
nanodots encapsulated in poly(styrene-co-maleic anhydride) (DC-CNDs@PSMA) (scale bar = 100 µm). b) In vivo optical bioimaging after intravenous 
injection of DC-CNDs@PSMA to mice.
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The two emission centers showed no spatial overlap and the 
quantum yield of the red emission center showed the highest 
value among red-emissive CNDs. The DC-CNDs showed the 
minimal cytotoxicity and demonstrated the great potential as 
a bioimaging agent for multicolor bioimaging, two-photon 
microscopy, and in vivo optical imaging. Moreover, DC-CNDs 
could be successfully exploited for optogenetic applications via 
the wavelength-dependent activation of ion channels. Taken 
together, we could confirm the feasibility of DC-CNDs with 
the unique characteristics of multicolor-emitting, facile and 
robust preparation, and biocompatibility for various biomedical 
applications.
Figure 4. a) Confocal microscopic image to show the bright fluorescence of tag yellow fluorescent protein (YFP), reflecting the successful transfec-
tion of the plasmid with channel rhodopsin-2 (ChR2) into HEK293T cells (scale bar = 100 µm). b) Confocal microscopic images of ChR2-introduced 
HEK293T cells before (left) and after (right) illumination of 405 nm laser to show the dual-color-emitting carbon nanodots (DC-CNDs) and the changes 
in the calcium indicator intensity after optogenetic activation of ChR2 (blue: DC-CND, red: calcium indicator, scale bar = 25 µm). c) The quantification 
of calcium indicator intensity in (b) (***P < 0.001 vs ChR2-introduced cells without DC-CND treatment).
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from the author.
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